Plasma cell leukemia is a rare subtype of plasma cell dyscrasias with an aggressive clinical course and poor prognosis. Despite significant advancements in therapeutics for multiple myeloma, we continue to have poor outcomes in patients with plasma cell leukemia. In this chapter, the clinical presentation and diagnosis of plasma cell leukemia are reviewed, as well as a summary of current data available on treatment options and potential future treatment directions for this difficult disease entity.
CITATION STYLE
Joseph, N. S., & Lonial, S. (2018). Plasma cell leukemia. In Neoplastic Diseases of the Blood (pp. 639–644). Springer International Publishing. https://doi.org/10.1007/978-3-319-64263-5_34
Mendeley helps you to discover research relevant for your work.